We are located in a beautiful
area known as the Ozarks

Medavera, Inc.
1200 E. Woodhurst, Building P
Springfield, MO 65804

Phone: 417.890.9722

For content questions:
Jill A. Sellers, BSPharm, PharmD
jill@medavera.com

For certificate and general questions:
Carrie Vause, MS
carrie@medavera.com

Office Image
CONTACT US
SEND THIS FORM
THE MEDICAL NEWS
GENEVA (Reuters) - The United Kingdom violates women's rights in Northern Ireland by unduly restricting their access to abortion, a report by the U.N. Committee on the Elimination of Discrimination against Women (CEDAW) said on Friday.... HINDHEAD, England (Reuters) - For 93-year-old Daphne Padfield, a dementia sufferer in an English care home, the arrival of a virtual reality (VR) headset offered a window back to the day in 1953 when Britain crowned its new queen.... (Reuters) - A European Medicines Agency (EMA) panel on Friday recommended against approving Puma Biotechnology's lead breast cancer drug, an outcome the U.S drugmaker had signaled last month.... (Reuters Health) - People who get minimally-invasive surgery to replace damaged heart valves have an easier time completing daily tasks and a better quality of life after the procedure, a research review suggests.... (Reuters Health) - The majority of people believe cardiopulmonary resuscitation (CPR) is successful more often than it tends to be in reality, according to a small U.S. study.... (Reuters) - KemPharm Inc said on Friday the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain, sending the shares of the drugmaker up as much as 36 percent in late afternoon trading.... (Reuters Health) - Some diabetics with plaque buildup in their arteries might have less debris in these blood vessels after adding wine to their diets, a recent study suggests.... (Reuters Health) - Older adults who have elective surgery are more likely to experience delirium afterwards when they’re frail, a research review suggests.... (Reuters) - U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday.... (Reuters Health) - Men who drink alcohol in late adolescence are more likely to develop severe liver disease decades later than young people who don’t drink at all, a Swedish study suggests....